TRxADE HEALTH (MEDS) Stock Chart & Stock Price History $1.45 -0.01 (-0.68%) As of 07/3/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock TRxADE HEALTH Stock Price Performance The TRxADE HEALTH (MEDS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 91.44%, with a year-to-date return of -76.61%. In the past month, the stock has increased 39.42%, reflecting recent market activity. As of the latest close, TRxADE HEALTH traded at $1.46 with a market cap of $2.05 million and volume of 513,083 shares. Five years ago, the stock traded at a split-adjusted price of $89.40, representing a 98.38% decrease over that period. At the time, it had a market cap of $47.75 million and a volume of 1,103 shares. Receive MEDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+12.40%1 Month Performance+39.42%3 Month Performance+50.65%Year-To-Date Performance-76.61%1 Year Performance-91.44%5 Year Performance-98.38% MEDS Stock Chart for Monday, July, 7, 2025 MEDS Chart by TradingView TRxADE HEALTH Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$1.46$1.45-0.68%$1.50$1.39173,670 shs$2.04 million07/03/2025$1.29$1.46+13.18%$1.58$1.26513,083 shs$2.05 million07/02/2025$1.04$1.29+24.04%$1.29$1.01255,702 shs$1.81 million07/01/2025$0.94$1.04+11.17%$1.04$0.95116,368 shs$1.46 million06/30/2025$0.94$0.94$0.97$0.9379,197 shs$1.32 million06/27/2025$0.92$0.98+6.11%$1.09$0.96151,028 shs$1.38 million06/26/2025$0.92$0.92$0.94$0.88129,746 shs$1.30 million06/25/2025$0.90$0.92+2.39%$0.94$0.88129,746 shs$1.30 million06/24/2025$0.91$0.90-1.24%$0.95$0.8986,895 shs$1.27 million06/23/2025$0.91$0.91$1.04$0.91143,864 shs$1.28 million Get the Latest News and Ratings for MEDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$0.99$0.99$1.00$0.9555,346 shs$1.40 million06/19/2025$0.96$0.99+3.64%$1.00$0.9555,346 shs$1.40 million06/18/2025$1.07$0.96-10.24%$1.10$0.95243,897 shs$1.35 million06/17/2025$1.07$1.07$1.13$1.00100,035 shs$1.50 million06/16/2025$1.07$1.07$1.13$1.00100,035 shs$1.50 million06/13/2025$1.19$1.12-6.30%$1.16$1.06111,282 shs$1.57 million06/12/2025$1.15$1.19+3.48%$1.19$1.10202,143 shs$1.67 million06/11/2025$1.10$1.15+4.55%$1.17$1.10107,127 shs$1.62 million06/10/2025$1.06$1.10+3.77%$1.16$1.00181,695 shs$1.55 million06/09/2025$1.06$1.06$1.08$1.0099,337 shs$1.49 million06/06/2025$0.94$1.04+10.70%$1.09$0.94192,565 shs$1.46 million Related Companies Greenlane Stock Chart urban-gro Stock Chart Aquaron Acquisition Stock Chart Cheetah Net Supply Chain Service Stock Chart JX Luxventure Stock Chart Alkaline Water Stock Chart Cuentas Stock Chart BIMI Stock Chart Alliance Entertainment Stock Chart CHS Stock Chart Receive MEDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MEDS) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRxADE HEALTH With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
